Dr. Martens plc
DOCMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $504 | $862 | $1,476 | $2,459 |
| - Cash | $156 | $111 | $158 | $228 |
| + Debt | $404 | $477 | $446 | $394 |
| Enterprise Value | $752 | $1,228 | $1,765 | $2,624 |
| Revenue | $788 | $877 | $1,000 | $908 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | $512 | $503 | $564 | $542 |
| % Margin | 65% | 57.3% | 56.4% | 59.7% |
| EBITDA | $111 | $196 | $204 | $266 |
| % Margin | 14% | 22.4% | 20.4% | 29.3% |
| Net Income | $5 | $69 | $129 | $181 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | $196 | $168 | $72 | $174 |
| Capital Expenditures | -$19 | -$28 | -$51 | -$25 |
| Free Cash Flow | $178 | $140 | $20 | $149 |